These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

47 related articles for article (PubMed ID: 1584450)

  • 1. [Therapeutic plans for the treatment of HPV infections by systemic administration of interferon-alpha. Experience with preneoplastic pathology of the uterine cervix associated with viral cytopathic effects].
    Zarcone R; Cardone G; Addonizio D; Cardone A
    Minerva Ginecol; 1992 Apr; 44(4):193-5. PubMed ID: 1584450
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between cytokines and HPV-16, HPV-16 E6, E7, and high-risk HPV viral load in the uterine cervix.
    Song SH; Lee JK; Seok OS; Saw HS
    Gynecol Oncol; 2007 Mar; 104(3):732-8. PubMed ID: 17188341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Immunologic response to (pre)neoplastic cervical lesions associated with human papillomavirus].
    Delvenne P
    Bull Mem Acad R Med Belg; 2005; 160(5-6):287-93. PubMed ID: 16465783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors influencing the biological behaviour of cervical human papillomavirus (HPV) infections in prospectively followed-up women.
    Syrjänen K; Mäntyjärvi R; Väyrynen M; Holopainen H; Saarikoski S; Castrén O
    Arch Geschwulstforsch; 1985; 55(6):457-66. PubMed ID: 3002294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary note on the use of interferon alpha by peroral route in HPV lesions.
    Montevecchi L; Caprio G; Vecchione A
    Clin Ter; 2000; 151(1 Suppl 1):29-34. PubMed ID: 10876964
    [No Abstract]   [Full Text] [Related]  

  • 6. 13-cis-retinoic acid or all-trans-retinoic acid plus interferon-alpha in recurrent cervical cancer: a Southwest Oncology Group phase II randomized trial.
    Weiss GR; Liu PY; Alberts DS; Peng YM; Fisher E; Xu MJ; Scudder SA; Baker LH; Moore DF; Lippman SM
    Gynecol Oncol; 1998 Dec; 71(3):386-90. PubMed ID: 9887236
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of microcolpohysteroscopy at an ambulatory center of level II preventive gynecologic oncology in the study of pre-neoplastic lesions of the uterine cervix].
    Vigada G; Malanetto C
    Minerva Ginecol; 1995 May; 47(5):183-7. PubMed ID: 7478082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Biology of the papillomavirus infections: V. Vaccine developments].
    Seilles E; Riethmuller D; Mougin C
    Ann Biol Clin (Paris); 1999; 57(5):517-24. PubMed ID: 10518053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cervical intraepithelial neoplasia treated by perilesional injection of interferon.
    Choo YC; Seto WH; Hsu C; Merigan TC; Tan YH; Ma HK; Ng MH
    Br J Obstet Gynaecol; 1986 Apr; 93(4):372-9. PubMed ID: 3964615
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical identification of human papillomavirus infection in tissues from cervical precancerous and early cancerous lesions among Indian women.
    Sharma BK; Gupta MM; Das DK; Singh V; Luthra UK
    Ann Biol Clin (Paris); 1988; 46(2):113-5. PubMed ID: 2837927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathognomonic signs of human papillomavirus infection in diagnostic material from the uterine cervix].
    Isakova LM; Ganina KP; Ivanova IM
    Arkh Patol; 1990; 52(12):39-42. PubMed ID: 1965392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Therapeutic plans for the management of HPV infections by topical application of interferon-alpha. Experience with vulvar infections].
    Zarcone R; Cardone G; Voto RI; Deconciliis B; Cardone A
    Minerva Ginecol; 1992 Apr; 44(4):189-91. PubMed ID: 1316575
    [No Abstract]   [Full Text] [Related]  

  • 13. [Human papilloma virus (HPV) typing in preneoplastic and neoplastic lesions of the uterine cervix in the IX region-Chile].
    Melo A; Montenegro S; Hooper T; Capurro I; Roa JC; Roa I
    Rev Med Chil; 2003 Dec; 131(12):1382-90. PubMed ID: 15022400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Local effect of the cytostatic agents SPG-gel 6 percent (Sandoz) on precancerous conditions of the uterine cervix].
    Kanka J; Stolz J; Subrt I; Havigerová I
    Cesk Gynekol; 1969 Jul; 34(6):372-4. PubMed ID: 5800094
    [No Abstract]   [Full Text] [Related]  

  • 15. Current concepts in the relationship of human papillomavirus infection to the pathogenesis and classification of precancerous squamous lesions of the uterine cervix.
    Ambros RA; Kurman RJ
    Semin Diagn Pathol; 1990 Aug; 7(3):158-72. PubMed ID: 2171125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral use of interferon therapy in cervical human papillomavirus infection.
    Palomba M; Melis GB
    Clin Ter; 2000; 151(1 Suppl 1):59-61. PubMed ID: 10876967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral progestins and regression of carcinoma in situ and cervical dysplasia. A cytologic evaluation.
    Ayre JE; Reyner FC; Fagundes WB; Leguerrier JM
    Obstet Gynecol; 1969 Oct; 34(4):545-60. PubMed ID: 5822680
    [No Abstract]   [Full Text] [Related]  

  • 18. [Vaccines for precancer and cancer of the uterine cervix. II. Therapeutic HPV vaccines].
    Kostova P; Zlatkov V
    Akush Ginekol (Sofiia); 2007; 46(8):31-5. PubMed ID: 18642554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The role of the cytological screening, HPV-test and the colposcopy for early detection of the precancerous lesions of the uterine cervix].
    Ivanov S
    Akush Ginekol (Sofiia); 2007; 46(9):45-9. PubMed ID: 18646309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Dysplasia and carcinoma in situ of the uterine cervix. Outcome of several cases].
    Minucci D; Guida G; Rabasso A
    Minerva Ginecol; 1975 May; 27(5):399-403. PubMed ID: 1134690
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.